Quick urine test could help people with HIV stay on track

NCT ID NCT04341779

Ongoing Disease control Sponsor: University of Washington Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether giving people with HIV same-day results from a simple urine test and a viral load test can help them stick to their medication and keep the virus under control. About 539 people starting HIV treatment in South Africa will take part. The goal is to see if this approach improves health outcomes and is cost-effective.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: point-of-care viral load and tenofovir adherence testing
What this could lead to: If successful, this approach could make HIV monitoring simpler and more effective, helping more people stay on treatment and keep the virus suppressed.
What could go wrong: This is a single-site study in South Africa, so results may not apply elsewhere. The intervention is a testing strategy, not a new drug, so benefits may be modest.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV-1-INFECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

AIDS HIV infectious disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV-1-INFECTION HIV/AIDS

Contacts and locations

Locations

Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal

Durban, KwaZulu-Natal, 4013, South Africa

More trials for these conditions

Other studies related to the condition(s) this trial covers.